$5.90
00.00%
Last update: 10:45 AM
15 minutes delayed
Foghorn Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Foghorn Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
FHTX | Foghorn Therapeutics | -$0.70 | -$0.65 | — | — | $5.60M | $6.04M | — | — | 08/02/2024 | Get Alert |
FHTX | Foghorn Therapeutics | -$0.73 | -$0.63 | -$0.59 | 6.35% | $5.31M | $6.91M | $5.05M | -26.92% | 05/06/2024 | Get Alert |
FHTX | Foghorn Therapeutics | -$0.69 | -$0.76 | -$0.57 | 25.00% | $4.18M | $4.62M | $5.77M | 24.87% | 03/07/2024 | Get Alert |
FHTX | Foghorn Therapeutics | -$0.62 | -$0.75 | -$0.34 | 54.67% | $6.63M | $4.52M | $17.48M | 286.68% | 11/02/2023 | Get Alert |
FHTX | Foghorn Therapeutics | -$0.66 | -$0.73 | -$0.70 | 4.11% | $4.49M | $6.26M | $5.60M | -10.56% | 08/04/2023 | Get Alert |
FHTX | Foghorn Therapeutics | -$0.65 | -$0.72 | -$0.73 | -1.39% | $3.92M | $5.04M | $5.31M | 5.34% | 05/08/2023 | Get Alert |
FHTX | Foghorn Therapeutics | -$0.77 | -$0.62 | -$0.69 | -11.29% | $713.00K | $8.48M | $4.18M | -50.66% | 03/09/2023 | Get Alert |
FHTX | Foghorn Therapeutics | -$0.71 | -$0.62 | -$0.62 | 0.00% | $41.00K | $9.20M | $6.63M | -27.89% | 11/08/2022 | Get Alert |
FHTX | Foghorn Therapeutics | -$0.63 | -$0.59 | -$0.66 | -11.86% | $279.00K | $8.69M | $4.49M | -48.33% | 08/09/2022 | Get Alert |
FHTX | Foghorn Therapeutics | -$0.62 | — | -$0.65 | — | $286.00K | — | $3.92M | — | 05/09/2022 | Get Alert |
FHTX | Foghorn Therapeutics | $2.53 | -$0.74 | -$0.77 | -4.05% | $251.00K | $330.00K | $713.00K | 116.06% | 03/10/2022 | Get Alert |
FHTX | Foghorn Therapeutics | -$3.12 | — | -$0.71 | — | $179.00K | — | $41.00K | — | 11/09/2021 | Get Alert |
FHTX | Foghorn Therapeutics | — | — | -$0.63 | — | — | — | $279.00K | — | 08/10/2021 | Get Alert |
FHTX | Foghorn Therapeutics | — | — | -$0.62 | — | — | — | $286.00K | — | 05/11/2021 | Get Alert |
FHTX | Foghorn Therapeutics | — | — | $2.53 | — | — | — | $251.00K | — | 03/18/2021 | Get Alert |
FHTX | Foghorn Therapeutics | — | — | -$3.12 | — | — | — | $179.00K | — | 12/04/2020 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-06 | $-0.59 | $-0.63 | 6.35 % |
Dec 2023 | 2024-03-07 | $-0.57 | $-0.76 | 25.0 % |
Sep 2023 | 2023-11-02 | $-0.34 | $-0.75 | 54.7 % |
Jun 2023 | 2023-08-04 | $-0.70 | $-0.73 | 4.11 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-06 | $5.05M | $6.91M | -26.9 % |
Dec 2023 | 2024-03-07 | $5.77M | $4.62M | 24.9 % |
Sep 2023 | 2023-11-02 | $17.48M | $4.52M | 286.7 % |
Jun 2023 | 2023-08-04 | $5.60M | $6.26M | -10.6 % |
Foghorn Therapeutics (FHTX) is scheduled to report earnings on August 2, 2024. The last reported earnings were for reported on May 6, 2024 for Q1.
The Actual EPS was $-0.59, which beat the estimate of $-0.63.
The Actual Revenue was $5M, which missed the estimate of $6.9M.
Browse earnings estimates, EPS, and revenue on all stocks.